SB 298 DE
AN ACT TO AMEND TITLES 3 AND 16 OF THE DELAWARE CODE RELATING TO HEMP.
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Summary
This act amends Delaware law to provide clearer definitions and guidelines distinguishing legal hemp and hemp-derived cannabinoid products (HDCPs) from marijuana and controlled substances. The act establishes clearer testing guidelines to determine the difference between these products, reducing confusion about what is and is not legal. The act is designed to provide clarity for businesses, consumers, and law enforcement regarding hemp and hemp-derived products. By clarifying the legal distinctions and acceptable testing methods, the act aims to eliminate uncertainty in how these products are classified and regulated. The amendments apply to titles 3 and 16 of the Delaware Code.
AI-generated plain-language summary of the bill (from the OpenStates abstract — no full text available yet) — neutral, and may be imperfect.
Official abstract
This Act adds clarity to distinguishing between legal hemp and hemp-derived cannabinoid products (HDCPs) and marijuana and controlled substances and provides clearer guidelines on acceptable tests for determining the difference to eliminate uncertainty for businesses, consumers, and law enforcement.
Sponsors (2)
- Kyra L. Hoffner Democratic · primary
- Sean M. Lynn Democratic · primary
Action history (2)
- May 4, 2026 Introduced and Assigned to Agriculture Committee in Senate · upper
- May 7, 2026 Re-Assigned to Executive Committee in Senate · upper
Full text
The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.
Comments
Data from OpenStates. View on OpenStates →
Comments